Published on
:
Key topics:
-
ASPI CEO Paul Mann expands globally with Renergen and Opeongo deals.
-
Opeongo investment secures a guaranteed customer for ASPI isotopes.
-
Strategy targets both supply (helium) and demand (medical isotopes).
Sign up for your early morning brew of the BizNews Insider to keep you up to speed with the content that matters. The newsletter will land in your inbox at 5:30am weekdays. Register here.
Support South Africa’s bastion of independent journalism, offering balanced insights on investments, business, and the political economy, by joining BizNews Premium. Register here.
If you prefer WhatsApp for updates, sign up for the BizNews channel here.
Loading content, please wait…
